Short-term effect of atorvastatin on endothelial function in healthy offspring of parents with Type 2 Diabetes Mellitus

Amudha, K; Choy, A. M.; Mustafa, M. R.; Lang, C.C. (2008) Short-term effect of atorvastatin on endothelial function in healthy offspring of parents with Type 2 Diabetes Mellitus. Cardiovascular Theraputics, 26 (4). pp. 253-261.

[img] PDF - Published Version
Restricted to Registered users only [error in script]

Download (630Kb) | Request a copy

    Abstract

    Endothelial function is impaired in healthy subjects at risk of type 2 diabetes mellitus (DM). We investigated whether endothelial dysfunction can be normalized by statin therapy in this potentially predisposed population. Flow-mediated dilation (FMD) was measured in 56 first-degree relatives (FDRs) (normotensive, normal glucose tolerance) and 20 age-, sex-, and BMI-matched controls with no family history of DM. Other measurements included insulin resistance index using the homeostasis model of insulin resistance (HOMAIR), plasma lipids, and markers of inflammation. The FDRs were then randomized and treated with atorvastatin (80 mg) or placebo daily in a 4-week double-blind, placebo-controlled trial. The FDRs had significantly impaired FMD (4.4 ± 8.1% vs. 13.0 ± 4.2%; P < 0.001), higher HOMAIR (1.72 ± 1.45 vs. 1.25 ± 0.43; P = 0.002), and elevated levels of plasma markers of inflammation—highly sensitive C-reactive protein (hsCRP) (2.6 ± 3.8 mg/L vs. 0.7 ± 1.0 mg/L; P = 0.06), interleukin (IL)-6 (0.07 ± 0.13 ng/mL vs. 0.03 ± 0.01 ng/mL; P < 0.001), and soluble intercellular adhesion molecule (sICAM) (267.7 ± 30.7 ng/mL vs. 238.2 ± 20.4 ng/mL; P < 0.001). FMD improved in the atorvastatin-treated subjects when compared with the placebo-treated subjects (atorvastatin, from 3.7 ± 8.5% to 9.8 ± 7.3%; placebo, from 3.9 ± 5.6% to 4.7 ± 4.2%; P = 0.001). There were also reductions in the levels of IL-6 (0.08 ± 0.02 ng/mL vs. 0.04 ± 0.01 ng/mL; P < 0.001) and hsCRP (3.0 ± 3.9 mg/L vs. 1.0 ± 1.3 mg/L; P = 0.006). Our study suggests that treatment with atorvastatin may improve endothelial function and decrease levels of inflammatory markers in FDRs of type 2 DM patients.

    Item Type: Article
    Creators:
    1. Amudha, K
    2. Choy, A. M.
    3. Mustafa, M. R.
    4. Lang, C.C.
    Journal or Publication Title: Cardiovascular Theraputics
    Additional Information: Department of Pharmacology and Medicine, University of Malaya, Kuala Lumpur, Malaysia
    Uncontrolled Keywords: Diabetes mellitus; endothelial function; statins
    Subjects: R Medicine > R Medicine (General)
    R Medicine > RM Therapeutics. Pharmacology
    Divisions: Faculty of Medicine
    Depositing User: Ms Haslinda Lahuddin
    Date Deposited: 30 Jan 2012 10:27
    Last Modified: 30 Jan 2012 10:27
    URI: http://eprints.um.edu.my/id/eprint/2522

    Actions (For repository staff only: Login required)

    View Item

    Document Downloads

    More statistics for this item...